Natural Health Trends Corp. will announce its financial results for the third quarter ending September 30, 2026, on October 28. The company, known for its premium personal care and wellness products under the NHT Global brand, will hold a conference call at 11:30 a.m. Eastern Time to discuss the results. Investors can access the call live or via replay on the company’s investor relations website. This update provides insight into the company’s recent performance and outlook.
Natural Health Trends' upcoming Q3 2026 financial results announcement provides context for Consumer Staples sector activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Oct 21, 2026 19:13 WIB: Of 63 priced US Consumer Staples stocks, 10 rose and 51 fell. Notable quotes include PepsiCo at USD 132.80 with Pluang order activity 79% Sell / 21% Buy and a typical hold time of 108 days, Constellation Brands at USD 131.61 with 0% Sell / 100% Buy and 0 days hold, and Monster Beverage at USD 46.65 with 100% Sell / 0% Buy and 73 days hold.
LegalZoom announced it will report its third quarter 2026 financial results on November 4, 2026, after market close. The company’s CEO and CFO will host a conference call and webcast to discuss the results. LegalZoom is a leading online legal service...
Schneider Electric introduced its RapidScale Modular Data Center Reference Design 115, a prefabricated blueprint optimized for AI infrastructure using NVIDIA's Vera Rubin platform and advanced liquid cooling. This design addresses the growing demand ...
Onward FX has chosen 173 startups from nearly 800 applicants for its fall program focused on physical economy sectors like energy, defense, and industrial technology. These startups will meet with investors including Eclipse, Chevron Technology Ventu...
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
